575 related articles for article (PubMed ID: 9183357)
1. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.
Barone FC; Arvin B; White RF; Miller A; Webb CL; Willette RN; Lysko PG; Feuerstein GZ
Stroke; 1997 Jun; 28(6):1233-44. PubMed ID: 9183357
[TBL] [Abstract][Full Text] [Related]
2. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.
Li DJ; Li YH; Yuan HB; Qu LF; Wang P
Metabolism; 2017 Mar; 68():31-42. PubMed ID: 28183451
[TBL] [Abstract][Full Text] [Related]
3. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
4. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression.
Barone FC; White RF; Spera PA; Ellison J; Currie RW; Wang X; Feuerstein GZ
Stroke; 1998 Sep; 29(9):1937-50; discussion 1950-1. PubMed ID: 9731622
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat.
Dawson DA; Martin D; Hallenbeck JM
Neurosci Lett; 1996 Oct; 218(1):41-4. PubMed ID: 8939476
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
7. SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice.
Barone FC; Lysko PG; Price WJ; Feuerstein G; al-Baracanji KA; Benham CD; Harrison DC; Harries MH; Bailey SJ; Hunter AJ
Stroke; 1995 Sep; 26(9):1683-9; discussion 1689-90. PubMed ID: 7660415
[TBL] [Abstract][Full Text] [Related]
8. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
9. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-α inhibition attenuates middle cerebral artery remodeling but increases cerebral ischemic damage in hypertensive rats.
Pires PW; Girgla SS; Moreno G; McClain JL; Dorrance AM
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H658-69. PubMed ID: 25015967
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
Hyakkoku K; Nakajima Y; Izuta H; Shimazawa M; Yamamoto T; Shibata N; Hara H
Neuroscience; 2009 Mar; 159(2):760-9. PubMed ID: 19166916
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Hosomi N; Ban CR; Naya T; Takahashi T; Guo P; Song XY; Kohno M
J Cereb Blood Flow Metab; 2005 Aug; 25(8):959-67. PubMed ID: 15729288
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha expression in ischemic neurons.
Liu T; Clark RK; McDonnell PC; Young PR; White RF; Barone FC; Feuerstein GZ
Stroke; 1994 Jul; 25(7):1481-8. PubMed ID: 8023366
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of TNF binding protein in focal cerebral ischemia.
Nawashiro H; Martin D; Hallenbeck JM
Brain Res; 1997 Dec; 778(2):265-71. PubMed ID: 9459543
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline attenuates TNF-α protein levels and brain edema following temporary focal cerebral ischemia in rats.
Vakili A; Mojarrad S; Akhavan MM; Rashidy-Pour A
Brain Res; 2011 Mar; 1377():119-25. PubMed ID: 21219888
[TBL] [Abstract][Full Text] [Related]
16. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats.
Britton P; Lu XC; Laskosky MS; Tortella FC
Life Sci; 1997; 60(20):1729-40. PubMed ID: 9150412
[TBL] [Abstract][Full Text] [Related]
17. Reduction of ischemic brain injury by anti-P-selectin monoclonal antibody after permanent middle cerebral artery occlusion in rat.
Suzuki H; Abe K; Tojo SJ; Kitagawa H; Kimura K; Mizugaki M; Itoyama Y
Neurol Res; 1999 Apr; 21(3):269-76. PubMed ID: 10319335
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia.
Lysko PG; Webb CL; Yue TL; Gu JL; Feuerstein G
Stroke; 1994 Dec; 25(12):2476-82. PubMed ID: 7974592
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia.
Meistrell ME; Botchkina GI; Wang H; Di Santo E; Cockroft KM; Bloom O; Vishnubhakat JM; Ghezzi P; Tracey KJ
Shock; 1997 Nov; 8(5):341-8. PubMed ID: 9361344
[TBL] [Abstract][Full Text] [Related]
20. MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain.
Bertorelli R; Adami M; Di Santo E; Ghezzi P
Neurosci Lett; 1998 Apr; 246(1):41-4. PubMed ID: 9622203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
